Cited by 154Gastroesophageal reflux and treatmentsGastrointestinal motility and disordersHelicobacter pylori-related gastroenterology studies

Diagnosis and management of non-erosive reflux disease–the Vevey NERD Consensus Group

Open access
Modlin, I.M., Hunt, R.H., Malfertheiner, P., Moayyedi, P., Quigley, E.M., Tytgat, G.N.J., Tack, J., Heading, R.C. +2 more·2009·Digestion

Abstract

BACKGROUND/AIMS: Although considerable information exists regarding gastroesophageal reflux disease with erosions, much less is known of non-erosive reflux disease (NERD), the dominant form of reflux disease in the developed world. METHODS: An expert international group using the modified Delphi technique examined the quality of evidence and established levels of agreement relating to different aspects of NERD. Discussion focused on clinical presentation, assessment of clinical outcome, pathobiological mechanisms, and clinical strategies for diagnosis and management. RESULTS: Consensus was reached on 85 specific statements. NERD was defined as a condition with reflux symptoms in the absence of mucosal lesions or breaks detected by conventional endoscopy, and without prior effective acid-suppressive therapy. Evidence supporting this diagnosis included: responsiveness to acid suppression therapy, abnormal reflux monitoring or the identification of specific novel endoscopic and histological findings. Functional heartburn was considered a separate entity not related to acid reflux. Proton pump inhibitors are the definitive therapy for NERD, with efficacy best evaluated by validated quality-of-life instruments. Adjunctive antacids or H(2) receptor antagonists are ineffective, surgery seldom indicated. CONCLUSIONS: Little is known of the pathobiology of NERD. Further elucidation of the mechanisms of mucosal and visceral hypersensitivity is required to improve NERD management.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000219365

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The findings are similar to what is observed in human microscopic reflux esophagitis, and would be assigned a Grade M in accordance with the updated Los Angeles classification.

    “These findings are similar to what is observed in human microscopic reflux esophagitis, and would be assigned a Grade M in accordance with the updated Los Angeles classification [2].”

    From Cytoprotective Effects of Hydrogen Sulfide in Novel Rat Models of Non-Erosive Esophagitis (2014) · cites this paper as [2]

    The section headed “Grade of evidence = Very low” describes microscopic histological changes in human non-erosive reflux disease, including basal zone hyperplasia and dilated intercellular spaces. It does not identify the citing paper’s findings, so their similarity cannot be assessed from this source; nor does it assign those changes Grade M under an updated Los Angeles classification. No page number is available in our copy. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • Postprandial hyperglycemia is a risk factor for acid reflux and the development of non-erosive esophagitis.

    “Postprandial hyperglycemia is a risk factor for acid reflux and the development of non-erosive esophagitis.”

    From Cytoprotective Effects of Hydrogen Sulfide in Novel Rat Models of Non-Erosive Esophagitis (2014) · cites this paper as [2]

    The section on weakly acidic reflux discusses acid exposure and symptom generation in NERD, but not postprandial blood glucose. Searches for postprandial hyperglycemia, glucose and diabetes found no passage linking elevated blood glucose to acid reflux or the development of non-erosive esophagitis; the paper instead identifies hiatus hernia as a risk factor for esophagitis. (LLM, conf=0.75)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

4 retracted

Flagged first, then by citations

Research works printed but not linked: 9

  1. Galmiche JP, Clouse RE, Balint A, Cook IJ, Kahrilas PJ, Paterson WG, Smout AJ: Func- tional esophageal disorders. Gastroenterol- ogy 2006; 130: 1459-1465.
  2. Sibbald B, Roberts C: Understanding con- trolled trials. Crossover trials. BMJ 1998; 316: 1719.
  3. Stanghellini V, Armstrong D, Monnikes H, Bardhan KD: Systematic review: do we need a new gastroesophageal reflux disease ques- tionnaire? Aliment Pharmacol Ther 2004; 19: 463-479.
  4. Flook N, Moayyedi P, Dent J, Talley NJ, Pers- son T, Karlson BW, Ruth M: Evaluation of symptom relief after one week of esomepra- zole therapy as a predictor of relief after 4 weeks in patients with unexplained chest pain: a randomized, double-blind, placebo- controlled, multicenter study (abstract). Gastroenterology 2007; 132:A483.
  5. Chen CL, Orr WC, Yang CC, Kuo TB: Car- diac autonomic regulation differentiates re- flux disease with and without erosive esoph- agitis. Scand J Gastroenterol 2006; 41: 1001-1006.
  6. Sifrim D, Mittal R, Fass R, Smout A, Castell D, Tack J, Gregersen H: Acidity and volume of the refluxate in the genesis of gastroesoph- ageal reflux disease symptoms. Aliment Pharmacol Ther 2007; 25: 1003-1017.
  7. Van Malenstein H, Farre R, Sifrim D: Esoph- ageal dilated intercellular spaces and non- erosive reflux disease. Am J Gastroenterol 2008; 103: 1021-1028.
  8. Fass R: Symptom assessment tools for gas- troesophageal reflux disease treatment. J Clin Gastroenterol 2007; 41: 437-444.
  9. Vakil N, Shaw M, Kirby R: Clinical effective- ness of laparoscopic fundoplication in a US community. Am J Med 2003; 114: 1-5.

Cited by

Sorted by citations

Authors
Modlin, I. M., Hunt, R. H., Malfertheiner, P., Moayyedi, P., Quigley, E. M., Tytgat, G. N. J., Tack, J., Heading, R. C., Holtman, G., & Moss, S. F.
Affiliations
  • Yale University (US)
  • McMaster University Medical Centre (CA)
  • Otto-von-Guericke-Universität Magdeburg (DE)
  • University College Cork (IE)
  • University of Amsterdam (NL)
  • KU Leuven (BE)
  • Glasgow Royal Infirmary (GB)
  • Brown University (US)
Venue
Digestion
Publisher
S. Karger AG
Published
2009
Volume
80
Issue
2
Pages
74-88
ISSN
  • 0012-2823 (ISSN-L)
  • 1421-9867
OpenAlex
W1990566132
Cited by
154
References
96
Citations by year
2026: 3 · 2025: 3 · 2024: 4 · 2023: 12 · 2022: 8 · 2021: 10 · 2020: 8 · 2019: 8 · 2018: 10 · 2017: 9 · 2016: 13 · 2015: 11 · 2014: 12 · 2013: 9 · 2012: 11
FWCI
12.04
Type
journal article
Language
en
Open access
Locations
  • Digestion (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Durham Research Online (Durham University) (acceptedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
  • Durham Research Online (Durham University) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Surgery › Helicobacter pylori-related gastroenterology studies
Keywords
non-erosive reflux disease, gastroesophageal reflux disease, proton pump inhibitors, acid suppression, functional heartburn, visceral hypersensitivity, reflux monitoring, antacids, H2 receptor antagonists, antireflux surgery, quality of life, pathobiology
MeSH terms
Gastroesophageal Reflux, Humans, Quality of Life, Severity of Illness Index, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review